Martin Shkreli settles all litigation with his former company Retrophin
Share:
NEW YORK (Reuters) - Martin Shkreli, the pharmaceutical entrepreneur serving a seven-year prison term for fraud, has settled all outstanding disputes with Retrophin Inc, the biopharmaceutical company he founded in 2011 and which ousted him three years later.A Retrophin spokeswoman said on Thursday that the accord covers Shkreli's $30 million (£23.6 million) lawsuit last month accusing three former colleagues, including his successor as chief executive, of engineering his ouster and to enrich..